Use of Network Pharmacology to Investigate the Mechanism by Which Allicin Ameliorates Lipid Metabolism Disorder in HepG2 Cells

Allicin has been well documented to exhibit a wide spectrum of biological activities, especially lipid-lowering activity, as a promising candidate for the management of nonalcoholic fatty liver disease (NALFD). However, the mechanisms underlying the therapeutic effects of allicin require further inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Bijun, Li, Tianjiao, Li, Fenglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815415/
https://www.ncbi.nlm.nih.gov/pubmed/33505493
http://dx.doi.org/10.1155/2021/3956504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815415/
https://www.ncbi.nlm.nih.gov/pubmed/33505493
http://dx.doi.org/10.1155/2021/3956504

Ejemplares similares